secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001503802-26-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm raises ~$50M via private placement and ATM; cash runway into late Q3 2026
--------------------------------------------------------------------------------

- Private placement with RA Capital Management closed March 26: 1.03M shares at $6.785, pre-funded warrants for 3.39M shares, and warrants for 4.42M shares at $10.00 exercise.
- Gross proceeds from private placement ~$30M; net proceeds from ATM sales of 2.99M shares ~$19.8M.
- Post-transaction shares outstanding 22.54M plus pre-funded warrants for 4.01M shares.
- Management expects existing liquidity, net product revenue, and license revenue to fund operations into late Q3 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000150380226000011/0001503802-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000150380226000011/kpti-20260327.htm
  HTML page:      https://secwatch.observer/filing/0001503802-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer